{"id":"https://openalex.org/W1977574151","doi":"https://doi.org/10.1002/(sici)1099-1077(199912)14:8<583::aid-hup143>3.0.co;2-k","title":"Naltrexone treatment in kleptomanic patients","display_name":"Naltrexone treatment in kleptomanic patients","publication_year":1999,"publication_date":"1999-12-01","ids":{"openalex":"https://openalex.org/W1977574151","doi":"https://doi.org/10.1002/(sici)1099-1077(199912)14:8<583::aid-hup143>3.0.co;2-k","mag":"1977574151"},"language":"en","primary_location":{"id":"doi:10.1002/(sici)1099-1077(199912)14:8<583::aid-hup143>3.0.co;2-k","doi":"https://doi.org/10.1002/(sici)1099-1077(199912)14:8<583::aid-hup143>3.0.co;2-k","is_oa":false,"landing_page_url":"https://doi.org/10.1002/(sici)1099-1077(199912)14:8<583::aid-hup143>3.0.co;2-k","pdf_url":null,"source":{"id":"https://openalex.org/S154207414","display_name":"Human Psychopharmacology Clinical and Experimental","issn_l":"0885-6222","issn":["0885-6222","1099-1077"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Psychopharmacology: Clinical and Experimental","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5105346936","display_name":"Pinhas N. Dannon","orcid":"https://orcid.org/0000-0002-4623-8140","observed_orcids":["https://orcid.org/0000-0002-4623-8140"]},"institutions":[{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]}],"countries":["IL"],"is_corresponding":true,"raw_author_name":"Pinhas N. Dannon","raw_affiliation_strings":["Chaim Sheba Medical Center, Anxiety Disorders Clinic, 52621 Tel Hashomer, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chaim Sheba Medical Center, Anxiety Disorders Clinic, 52621 Tel Hashomer, Israel","institution_ids":["https://openalex.org/I2799810450"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047150024","display_name":"Iulian Iancu","orcid":"https://orcid.org/0000-0002-4596-5661","observed_orcids":["https://orcid.org/0000-0002-4596-5661"]},"institutions":[{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Iulian Iancu","raw_affiliation_strings":["Chaim Sheba Medical Center, Anxiety Disorders Clinic, 52621 Tel Hashomer, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chaim Sheba Medical Center, Anxiety Disorders Clinic, 52621 Tel Hashomer, Israel","institution_ids":["https://openalex.org/I2799810450"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016000824","display_name":"Leon J. Grunhaus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799810450","display_name":"Sheba Medical Center","ror":"https://ror.org/020rzx487","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799810450"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Leon Grunhaus","raw_affiliation_strings":["Chaim Sheba Medical Center, Anxiety Disorders Clinic, 52621 Tel Hashomer, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chaim Sheba Medical Center, Anxiety Disorders Clinic, 52621 Tel Hashomer, Israel","institution_ids":["https://openalex.org/I2799810450"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5105346936"],"corresponding_institution_ids":["https://openalex.org/I2799810450"],"apc_list":{"value":4030,"currency":"USD","value_usd":4030},"apc_paid":null,"fwci":0.8804,"has_fulltext":false,"cited_by_count":53,"citation_normalized_percentile":{"value":0.74704379,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"14","issue":"8","first_page":"583","last_page":"585"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11123","display_name":"Obsessive-Compulsive Spectrum Disorders","score":0.8974999785423279,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11123","display_name":"Obsessive-Compulsive Spectrum Disorders","score":0.8974999785423279,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11705","display_name":"Gambling Behavior and Treatments","score":0.025100000202655792,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.012199999764561653,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kleptomania","display_name":"kleptomania","score":0.8870000243186951},{"id":"https://openalex.org/keywords/naltrexone","display_name":"naltrexone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/opioid-antagonists","display_name":"opioid antagonists","score":0.9290000200271606},{"id":"https://openalex.org/keywords/impulse-control-disorders","display_name":"impulse control disorders","score":0.9440000057220459},{"id":"https://openalex.org/keywords/drug-therapy","display_name":"pharmacotherapy","score":0.9660000205039978},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.3490000069141388}],"concepts":[{"id":"https://openalex.org/C2777972943","wikidata":"https://www.wikidata.org/wiki/Q409587","display_name":"Naltrexone","level":4,"score":0.931137204170227},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.5979401469230652},{"id":"https://openalex.org/C542102704","wikidata":"https://www.wikidata.org/wiki/Q183257","display_name":"Psychotherapist","level":1,"score":0.5404411554336548},{"id":"https://openalex.org/C3018727167","wikidata":"https://www.wikidata.org/wiki/Q6033829","display_name":"Impulse control","level":2,"score":0.5019314289093018},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.4790997803211212},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.46678626537323},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.46213239431381226},{"id":"https://openalex.org/C40010229","wikidata":"https://www.wikidata.org/wiki/Q3184856","display_name":"Substance abuse","level":2,"score":0.44589921832084656},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.43550994992256165},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4199259877204895},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2242649495601654},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.12854787707328796}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1002/(sici)1099-1077(199912)14:8<583::aid-hup143>3.0.co;2-k","doi":"https://doi.org/10.1002/(sici)1099-1077(199912)14:8<583::aid-hup143>3.0.co;2-k","is_oa":false,"landing_page_url":"https://doi.org/10.1002/(sici)1099-1077(199912)14:8<583::aid-hup143>3.0.co;2-k","pdf_url":null,"source":{"id":"https://openalex.org/S154207414","display_name":"Human Psychopharmacology Clinical and Experimental","issn_l":"0885-6222","issn":["0885-6222","1099-1077"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Psychopharmacology: Clinical and Experimental","raw_type":"journal-article"},{"id":"doi:10.1002/(sici)1099-1077(199912)14:8<583::aid-hup143>3.3.co;2-b","doi":"https://doi.org/10.1002/(sici)1099-1077(199912)14:8<583::aid-hup143>3.3.co;2-b","is_oa":false,"landing_page_url":"https://doi.org/10.1002/(sici)1099-1077(199912)14:8<583::aid-hup143>3.3.co;2-b","pdf_url":null,"source":{"id":"https://openalex.org/S154207414","display_name":"Human Psychopharmacology Clinical and Experimental","issn_l":"0885-6222","issn":["0885-6222","1099-1077"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Psychopharmacology: Clinical and Experimental","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W76372556","https://openalex.org/W110869054","https://openalex.org/W1549752994","https://openalex.org/W2024662992","https://openalex.org/W2077499557","https://openalex.org/W2084343677","https://openalex.org/W2088483018","https://openalex.org/W2416755305","https://openalex.org/W2419494262","https://openalex.org/W2502993979","https://openalex.org/W2514460021","https://openalex.org/W3207785198","https://openalex.org/W4236038590","https://openalex.org/W4238512511"],"related_works":["https://openalex.org/W2280745378","https://openalex.org/W2183474536","https://openalex.org/W2043095329","https://openalex.org/W2040592234","https://openalex.org/W2061911039","https://openalex.org/W4240892151","https://openalex.org/W2077216182","https://openalex.org/W4294202371","https://openalex.org/W181379459","https://openalex.org/W7062999501"],"abstract_inverted_index":{"Kleptomania":[0],"is":[1],"an":[2,45],"impulse":[3,60],"control":[4,61],"disorder":[5],"and":[6,16,27,59],"that":[7],"can":[8],"be":[9,64],"treated":[10,81],"with":[11,35,82],"the":[12,31,54,68],"combination":[13],"of":[14,56,70],"pharmacotherapy":[15],"psychotherapy.":[17],"The":[18],"most":[19],"common":[20],"drug":[21],"regimens":[22],"include":[23],"antidepressants,":[24],"especially":[25],"SSRIs":[26],"mood":[28],"stabilizers.":[29],"However,":[30],"low":[32],"efficacy":[33],"rates":[34],"these":[36],"drugs":[37],"urge":[38],"research":[39],"for":[40],"new":[41],"treatment":[42,55,69],"regimens.":[43],"Natrexone,":[44],"opioid":[46],"receptor":[47],"antagonist,":[48],"which":[49],"has":[50],"been":[51],"used":[52],"in":[53,67],"substance":[57],"abuse":[58],"disorders,":[62],"may":[63],"also":[65],"useful":[66],"kleptomania.":[71],"In":[72],"this":[73],"study":[74],"we":[75],"report":[76],"two":[77],"kleptomanic":[78],"patients":[79],"successfully":[80],"naltrexone.":[83],"Copyright":[84],"\u00a9":[85],"1999":[86],"John":[87],"Wiley":[88],"&":[89],"Sons,":[90],"Ltd.":[91]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2012,"cited_by_count":30}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}